一种b型流感嗜血杆菌结合疫苗分子大小分析的HPSEC方法

来源 :2013中国药学大会暨第十三届中国药师周 | 被引量 : 0次 | 上传用户:metor2009
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:建立一种高效大小排阻色谱(HPSEC)方法检测b型流感嗜血杆菌(Hib)结合疫苗分子大小分布.方法:采用TSK G6000PW色谱柱,1.0%(w/v)Na2SO4作为流动相,流速设置为0.4ml/min,紫外检测波长为206nm,并连接激光散射检测器(MALS),对Hib结合疫苗的原液和制剂样品进行分子大小分布的检测;将该结果与CL-4B凝胶柱检测的结果进行比较.同时对一组原液和制剂样品进行高温处理,用HPSEC法和CL-4B色谱法分析样品降解趋势.结果:HPSEC法可以对小量的以CRM197为载体的Hib结合疫苗进行分子大小分布的检测,每个样品的检测时间仅需40分钟,其检测结果与CL-4B色谱法的结果有着良好的相关性;HPSEC与激光散射检测器相连可以用来进行Hib结合疫苗的重均分子量的测定;通过对一组高温处理的样品进行分析,HPSEC法能够准确地反映出样品的降解趋势,与CL-4B色谱法的结果有着良好的可比性.结论:HPSEC法是一种比CL-4B色谱法检测更高效的分子大小测定方法.
其他文献
会议
OBJECTIVES: Because the effects of lower-dose oral cobalamin (Cbl) supplements on older people with cobalamin deficiency are not known,we determined whether oral Cbl supplements at three different dos
OBJECTIVES: To document the experiences of patients,their caregivers,healthcare personnel,and staff members with a program that provides telemedicine-enhanced emergency care to older adults residing i
The aim of this article is to introduce a systematic,structured conceptual framework for the comparative analysis of welfare-state reform policies towards long-term senior care and the care structures
会议
会议
本文介绍了由国家科技部、中国医药国际交流中心和国家健康科技产业基地举办的首届欧洲推介会议,重点讨论了各国制药厂技术经验交流情况,为医药企业引进国外先进技术,开拓国际市场提供依据.
Human La protein (hLa) is a multifunctional RNA-binding protein involved in the regulation of hepatitis B virus (HBV) expression.Casein kinase Ⅱ (CK2),a protein kinase,is known to activate hLa by phos
Background: Over 350 million people worldwide are infected with hepatitis B virus (HBV),a major cause of liver failure and hepatocellular carcinoma.Current therapeutic agents are highly effective,but
The human La (hLa) protein functions in RNA metabolism and is activated by casein kinase 2 (CK2) phosphorylation.Hepatitis B virus (HBV) can exploit hLa to stabilize its RNA and promote its pathogenes